Evidence map›Paper›PMID 39906406›Full record

ArticleBulletin de l'Academie nationale de medecine2024

[Advances and perspectives in vascularized composite allotransplantation preservation].

Yanis Berkane, Haizam Oubari, Elise Lupon, Marion Goutard, Pierre Tawa, Mark A Randolph, Curtis L Cetrulo, Nicolas Bertheuil, Alexandre G Lellouch, Korkut Uygun

Abstract readEnglish Abstract
In one paragraph

Article in Bulletin de l'Academie nationale de medecine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yanis BerkaneCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, États-Unis.
Haizam OubariCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, États-Unis.
Elise LuponCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, États-Unis.
Marion GoutardCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, États-Unis.
Pierre TawaCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, États-Unis.
Mark A RandolphShriners Children's Boston, Harvard Medical School, Boston, MA, États-Unis.
Curtis L CetruloShriners Children's Boston, Harvard Medical School, Boston, MA, États-Unis.
Nicolas BertheuilService de chirurgie plastique, reconstructrice et esthétique, CHU de Rennes, université de Rennes, Rennes, France.
Alexandre G LellouchCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, États-Unis.
Korkut UygunCenter for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, États-Unis.

Funding

Genetic-engineered control of the immunogeneic state of vascular composite allografts during preservationR01EB028782 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Biju Parekkadan, Korkut Uygun · 2021 to 2026
$3.1M
Subzero preservation of vascular composite allograftsR56AI171958 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BISCHOF, JOHN C, FINGER, ERIK BRIAN · 2022 to 2022
$546k
NIAID NIH HHS R56 AI171958NIBIB NIH HHS R01 EB028782
6 · The paper itself

Abstract

Vascularized composite allotransplantation (VCA) involves transplants of the face, upper limb, trachea, penis, abdominal wall and, more recently, uterus. These grafts are unique in that they comprise numerous specialized tissues derived from several embryonic layers, each with its own specific constraints. Whereas the skin component, as an immunological barrier, is a real challenge in terms of immune tolerance, the muscle is highly sensitive to ischemia, and ischemia-reperfusion injuries can lead to antigen release and eventually rejection episodes. While the gold standard for the preservation of these grafts remains static cold storage (4 °C), the emergence of dynamic perfusion techniques in solid organ transplantation suggests their adaptation to VCAs. In this review, we outline the challenges imposed by composite tissue allotransplantation, and discuss the latest advances in VCA preservation based on machine perfusion but also on static techniques at negative temperatures. Particular attention is paid to subnormothermic perfusion preservation and supercooling techniques, developed by our team in an attempt to import these optimized techniques from solid organ preservation.

Indexed as

Composite tissue allograftsCryopreservation/methodsOrgan preservationOrgan preservation/methodsPerfusion/methodsVascularized composite allotransplantation

Identifiers

PMID39906406
PMCPMC11790288

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.